PNC Financial Services Group’s Clearside Biomedical CLSD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86.3K | Hold |
107,919
| – | – | ﹤0.01% | 2808 |
|
|
2025
Q1 | $99.1K | Sell |
107,919
-325
| -0.3% | -$298 | ﹤0.01% | 2667 |
|
|
2024
Q4 | $103K | Buy |
108,244
+325
| +0.3% | +$309 | ﹤0.01% | 2664 |
|
|
2024
Q3 | $137K | Buy |
107,919
+102,333
| +1,832% | +$130K | ﹤0.01% | 2470 |
|
|
2024
Q2 | $7.26K | Hold |
5,586
| – | – | ﹤0.01% | 3889 |
|
|
2024
Q1 | $8.55K | Hold |
5,586
| – | – | ﹤0.01% | 3805 |
|
|
2023
Q4 | $6.54K | Hold |
5,586
| – | – | ﹤0.01% | 3866 |
|
|
2023
Q3 | $4.86K | Hold |
5,586
| – | – | ﹤0.01% | 4003 |
|
|
2023
Q2 | $6.26K | Hold |
5,586
| – | – | ﹤0.01% | 4048 |
|
|
2023
Q1 | $5.81K | Hold |
5,586
| – | – | ﹤0.01% | 3989 |
|
|
2022
Q4 | $6.26K | Hold |
5,586
| – | – | ﹤0.01% | 3920 |
|
|
2022
Q3 | $6K | Hold |
5,586
| – | – | ﹤0.01% | 3912 |
|
|
2022
Q2 | $8K | Hold |
5,586
| – | – | ﹤0.01% | 3873 |
|
|
2022
Q1 | $13K | Hold |
5,586
| – | – | ﹤0.01% | 3749 |
|
|
2021
Q4 | $15K | Hold |
5,586
| – | – | ﹤0.01% | 3652 |
|
|
2021
Q3 | $34K | Hold |
5,586
| – | – | ﹤0.01% | 3273 |
|
|
2021
Q2 | $27K | Hold |
5,586
| – | – | ﹤0.01% | 3350 |
|
|
2021
Q1 | $14K | Hold |
5,586
| – | – | ﹤0.01% | 3534 |
|
|
2020
Q4 | $15K | Hold |
5,586
| – | – | ﹤0.01% | 3439 |
|
|
2020
Q3 | $9K | Buy |
+5,586
| New | +$9K | ﹤0.01% | 3526 |
|
|
2018
Q3 | – | Sell |
-1,200
| Closed | -$13K | – | 4123 |
|
|
2018
Q2 | $13K | Buy |
+1,200
| New | +$13K | ﹤0.01% | 3595 |
|